trade name for tirzepatide Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Tirzepatide (ZEPBOUND) Approved for Chronic

Risk of suicide, hair loss, and aspiration with GLP1-receptor agonists and other diabetic agents: a Real-World Pharmacovigilance Study

Efforts to gather this information are ongoing, and we will hopefully have more insight in the near future

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. The New England journal of medicine, 10.1056/NEJMoa2301972

Report suspected product quality issues to the compounding pharmacy and to the FDA MedWatch program

Lately theres been a wave of products like Inno Shred GLP-1 that market themselves as weight-loss game changers, but they dont have semaglutide, tirzepatide, or any other GLP-1 meds inside